HIV/AIDS: Promising results from infant treatment with protease inhibitor lopinavir LPV/r, study suggests

A clinical study of anti-HIV/AIDS medicines in the developing world is on the verge of turning "the whole treatment world on its head," according to pediatrician researchers. New treatment with LPV/r proved superior enough for WHO to recommend that infants with HIV infection and exposure to NVP at birth start on an LPV/r-based regimen whenever possible.

Read the whole article on Science Daily

More from Science Daily